del-giacco-s 1

1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
3. Management of anaphylaxis due to COVID-19 vaccines in the elderly
4. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
5. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
6. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
1